{
  "pmid": "33332292",
  "uid": "33332292",
  "title": "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.",
  "abstract": "On December 11, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine (Pfizer, Inc; Philadelphia, Pennsylvania), a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) (1). Vaccination with the Pfizer-BioNTech COVID-19 vaccine consists of 2 doses (30 μg, 0.3 mL each) administered intramuscularly, 3 weeks apart. On December 12, 2020, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation* for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years for the prevention of COVID-19. To guide its deliberations regarding the vaccine, ACIP employed the Evidence to Recommendation (EtR) Framework,[†] using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.[§] The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP's interim recommendation for allocating initial supplies of COVID-19 vaccines (2). The ACIP recommendation for the use of the Pfizer-BioNTech COVID-19 vaccine under EUA is interim and will be updated as additional information becomes available.",
  "authors": [
    {
      "last_name": "Oliver",
      "fore_name": "Sara E",
      "initials": "SE",
      "name": "Sara E Oliver",
      "affiliations": []
    },
    {
      "last_name": "Gargano",
      "fore_name": "Julia W",
      "initials": "JW",
      "name": "Julia W Gargano",
      "affiliations": []
    },
    {
      "last_name": "Marin",
      "fore_name": "Mona",
      "initials": "M",
      "name": "Mona Marin",
      "affiliations": []
    },
    {
      "last_name": "Wallace",
      "fore_name": "Megan",
      "initials": "M",
      "name": "Megan Wallace",
      "affiliations": []
    },
    {
      "last_name": "Curran",
      "fore_name": "Kathryn G",
      "initials": "KG",
      "name": "Kathryn G Curran",
      "affiliations": []
    },
    {
      "last_name": "Chamberland",
      "fore_name": "Mary",
      "initials": "M",
      "name": "Mary Chamberland",
      "affiliations": []
    },
    {
      "last_name": "McClung",
      "fore_name": "Nancy",
      "initials": "N",
      "name": "Nancy McClung",
      "affiliations": []
    },
    {
      "last_name": "Campos-Outcalt",
      "fore_name": "Doug",
      "initials": "D",
      "name": "Doug Campos-Outcalt",
      "affiliations": []
    },
    {
      "last_name": "Morgan",
      "fore_name": "Rebecca L",
      "initials": "RL",
      "name": "Rebecca L Morgan",
      "affiliations": []
    },
    {
      "last_name": "Mbaeyi",
      "fore_name": "Sarah",
      "initials": "S",
      "name": "Sarah Mbaeyi",
      "affiliations": []
    },
    {
      "last_name": "Romero",
      "fore_name": "José R",
      "initials": "JR",
      "name": "José R Romero",
      "affiliations": []
    },
    {
      "last_name": "Talbot",
      "fore_name": "H Keipp",
      "initials": "HK",
      "name": "H Keipp Talbot",
      "affiliations": []
    },
    {
      "last_name": "Lee",
      "fore_name": "Grace M",
      "initials": "GM",
      "name": "Grace M Lee",
      "affiliations": []
    },
    {
      "last_name": "Bell",
      "fore_name": "Beth P",
      "initials": "BP",
      "name": "Beth P Bell",
      "affiliations": []
    },
    {
      "last_name": "Dooling",
      "fore_name": "Kathleen",
      "initials": "K",
      "name": "Kathleen Dooling",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "MMWR. Morbidity and mortality weekly report",
    "iso_abbreviation": "MMWR Morb Mortal Wkly Rep",
    "issn": "1545-861X",
    "issn_type": "Electronic",
    "volume": "69",
    "issue": "50",
    "pub_year": "2020",
    "pub_month": "Dec",
    "pub_day": "18"
  },
  "start_page": "1922",
  "end_page": "1924",
  "pages": "1922-1924",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Adolescent",
    "Adult",
    "Adverse Drug Reaction Reporting Systems",
    "Advisory Committees",
    "Aged",
    "Aged, 80 and over",
    "COVID-19",
    "COVID-19 Vaccines",
    "Drug Approval",
    "Humans",
    "Immunization",
    "Middle Aged",
    "Practice Guidelines as Topic",
    "United States",
    "Young Adult"
  ],
  "article_ids": {
    "pubmed": "33332292",
    "pmc": "PMC7745957",
    "doi": "10.15585/mmwr.mm6950e2"
  },
  "doi": "10.15585/mmwr.mm6950e2",
  "pmc_id": "PMC7745957",
  "dates": {
    "completed": "2020-12-18",
    "revised": "2021-01-01"
  },
  "chemicals": [
    "COVID-19 Vaccines"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:45:33.671284",
    "pmid": "33332292"
  }
}